Groesbeck Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-24,085
Closed -$2.45M 81
2015
Q4
$2.45M Sell
24,085
-886
-4% -$99.5K 1.56% 23
2015
Q3
$4.45M Hold
24,971
2.81% 10
2015
Q2
$5.55M Buy
24,971
+75
+0.3% +$16.6K 2.66% 12
2015
Q1
$4.95M Buy
24,896
+5,061
+26% +$898K 2.4% 17
2014
Q4
$2.84M Buy
19,835
+200
+1% +$26.9K 1.39% 28
2014
Q3
$2.58M Sell
19,635
-300
-2% -$35.8K 1.23% 31
2014
Q2
$2.51M Buy
19,935
+6,200
+45% +$791K 1.09% 41
2014
Q1
$1.81M Buy
13,735
+10,790
+366% +$1.48M 0.82% 49
2013
Q4
$346K Buy
+2,945
New +$323K 0.14% 68

Other funds holding BHC

Groesbeck Investment Management's BHC Position: Q1 2016 in Review

Groesbeck Investment Management sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 24,085 shares — an estimated $2.45M sold.

Groesbeck Investment Management first reported a position in BHC in Q4 2013 and held it in 9 quarters. The position peaked at $5.55M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • Groesbeck Investment Management reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • Groesbeck Investment Management sold 24,085 Bausch Health shares in Q1 2016, an estimated $2.45M.
  • Groesbeck Investment Management first reported a position in Bausch Health in Q4 2013 and held it in 9 quarters.
  • Groesbeck Investment Management's Bausch Health position peaked at $5.55M in Q2 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Groesbeck Investment Management's 13F filing for Q1 2016, filed 13 May 2016.